Hideyuki Kabasawa

发表

Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes

Y. Tomino, I. Narita, K. Yamagata, 2012, Diabetes Care.

Rice Endosperm Protein Improves the Anti-Inflammatory Effects of High-Density Lipoprotein and Produces Lower Atherosclerotic Lesion Accelerated by the Renal Mass Reduction than Casein in a Mouse Model.

I. Narita, V. Kon, M. Hosojima, 2021, Journal of the American College of Nutrition.

Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk.

A. Nishiyama, F. Gejyo, M. Hosojima, 2009, Endocrinology.

Urinary A- and C-megalin predict progression of diabetic kidney disease: a retrospective cohort study

N. Kitamura, I. Narita, Keiko Kabasawa, 2021 .

Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease

I. Narita, M. Hosojima, A. Saito, 2019, BMC Nephrology.

Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study

I. Narita, H. Kagamu, T. Kikuchi, 2019, BMC Cancer.

Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018

Yusuke Suzuki, Tetsuhiro Tanaka, M. Nangaku, 2018, Clinical and Experimental Nephrology.

The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring

I. Narita, M. Hosojima, A. Saito, 2017, Internal medicine.

Intradialytic parenteral nutrition using a standard amino acid solution not for renal failure in maintenance hemodialysis patients with malnutrition: a multicenter pilot study

I. Narita, M. Hosojima, A. Saito, 2022, Renal Replacement Therapy.

Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.

N. Kitamura, I. Narita, M. Hosojima, 2022, Journal of diabetes and its complications.

Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease.

N. Kitamura, A. Nishiyama, I. Narita, 2016, Journal of the American Society of Nephrology : JASN.

A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology

I. Narita, Yumi Ito, S. Nishi, 2013, CEN Case Reports.

Measurement of Plasma Glucagon Levels Using Mass Spectrometry in Patients with Type 2 Diabetes on Maintenance Hemodialysis

I. Narita, T. Kitamura, Masaki Kobayashi, 2021, Kidney and Blood Pressure Research.

An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis

I. Narita, M. Hosojima, A. Saito, 2022, Renal Replacement Therapy.

Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.

I. Narita, H. Kagamu, T. Kikuchi, 2017, Journal of the American Society of Nephrology : JASN.

Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury

H. Hirai, N. Koitabashi, Hiroki Matsui, 2021, The Journal of pathology.

A Randomized, Double-Blind, Crossover Pilot Trial of Rice Endosperm Protein Supplementation in Maintenance Hemodialysis Patients

S. Miyazaki, M. Hosojima, A. Saito, 2017, Scientific Reports.

Rice Endosperm Protein Administration to Juvenile Mice Regulates Gut Microbiota and Suppresses the Development of High-Fat Diet-Induced Obesity and Related Disorders in Adulthood

Shujiro Okuda, N. Kitamura, I. Narita, 2019, Nutrients.

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Scientific Reports.

Effects of DPP-4 Inhibitors on Blood Glucose Variability in Japanese Patients with Type 2 Diabetes on Maintenance Hemodialysis: A Prospective Observational Exploratory Study

N. Kitamura, I. Narita, M. Hosojima, 2020, Diabetes Therapy.

A Randomized, Double-Blind, Crossover Pilot Trial of Rice Endosperm Protein Supplementation in Maintenance Hemodialysis Patients

S. Miyazaki, M. Hosojima, A. Saito, 2017, Scientific Reports.

Rice protein ameliorates the progression of diabetic nephropathy in Goto-Kakizaki rats with high-sucrose feeding.

T. Kumagai, A. Saito, M. Kadowaki, 2013, The British journal of nutrition.

The endocytosis receptor megalin: from bench to bedside.

M. Hosojima, A. Saito, Hideyuki Kabasawa, 2023, The international journal of biochemistry & cell biology.

Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren’s syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature

I. Narita, Tomoyuki Ito, N. Imai, 2018, Modern rheumatology.

Exocytosis-Mediated Urinary Full-Length Megalin Excretion Is Linked With the Pathogenesis of Diabetic Nephropathy

T. Ochiya, I. Narita, Y. Yoshioka, 2017, Diabetes.

Pathogenic variants of Alport syndrome and monogenic diabetes identified by exome sequencing in a family

S. Goto, I. Narita, Yumi Ito, 2023, Human Genome Variation.

A case of idiopathic nodular glomerulosclerosis successfully treated by intensive blockade of the renin–angiotensin–aldosterone system

I. Narita, Yumi Ito, M. Arakawa, 2022, CEN Case Reports.

Efficacy of Low-Protein Rice for Dietary Protein Restriction in CKD Patients: A Multicenter, Randomized, Controlled Study

I. Narita, M. Hosojima, A. Saito, 2022, Kidney360.

Megalin is downregulated via LPS-TNF-α-ERK1/2 signaling pathway in proximal tubule cells.

I. Narita, R. Kaneko, A. Saito, 2011, Biochemical and Biophysical Research Communications - BBRC.

Megalin is involved in angiotensinogen-induced, angiotensin II-mediated ERK1/2 signaling to activate Na+-H+ exchanger 3 in proximal tubules

K. Tsumoto, S. Nagatoishi, A. Saito, 2023, Journal of hypertension.

Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study

I. Narita, T. Kitamura, Masaki Kobayashi, 2021, Diabetes Therapy.

R. Kaseda, Hideyuki Kabasawa, Hiroyuki Aoki, 2024, The Journal of pathology.

Cryo-EM structures elucidate the multiligand receptor nature of megalin

S. Nagatoishi, A. Tsutsumi, Yongchan Lee, 2024, Proceedings of the National Academy of Sciences of the United States of America.